Should MRE use current cash in hand to buy back its own shares? That will help current share holder get additional benefits.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025